Dr. Saad Kenderian
2021 was a year of significant innovation across the field of regenerative medicine at Mayo Clinic. Important advancements in preclinical research, as well as new [...]
Los investigadores de Mayo Clinic manipularon biológicamente y de forma novedosa la terapia de células T con [...]
Mayo Clinic researchers have biomanufactured chimeric antigen receptor-T cell therapy (CAR-T cell therapy) in a [...]
At the beginning of the pandemic, experimental therapies were the only options available to help patients. Turning them into standard care required clinical and translational [...]
SAN DIEGO: Los científicos de Mayo Clinic desarrollaron dos estrategias nuevas que podrían mejorar el rendimiento de la terapia de células [...]
SAN DIEGO — Mayo Clinic researchers have developed two new strategies that may improve the performance of chimeric antigen receptor therapy (CAR-T cell therapy) [...]
Chimeric antigen receptor-T cell therapy (CAR-T cell therapy) — a type of immunotherapy that reprograms a patient's T cells to recognize and [...]